Cytonics Corporation

Cynics is a company that develops a disease-modifying therapy for osteoarthritis. They have cleared phase 1 human trials and are advancing towards phase 1b/2a with a version engineered to be 200% more potent. They are backed by research from Stanford University and Scripps.

  • Headcount
  • Financials
  • Funding
  • Mergers & Acquisitions
  • Products and services
  • Similar companies

Get it all with one API call

from tavily import TavilyClientclient = TavilyClient(api_key="tvly-YOUR_API_KEY")response = client.extract(urls=["https://tavily.com/knowledge/company/DR92v5keNM4E"])print(response)
Get an API keyRead the docs

Tavily’s entity index compiles information from sources on the web. Information may be inaccurate, incomplete, or outdated, and entity resolution may incorrectly associate information with a person or company. Users should independently verify information before relying on it. To report inaccurate information or exercise your privacy rights, please visit our Privacy Requests page.